Company
BeyondSpring Inc. (BYSI)
Standardized SEC financial data for BeyondSpring Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001677940 · NASDAQ · Pharmaceutical Preparations.
Return on equity
4.2%
Free cash flow
-$19.8M
Debt / equity
0.00×
Current ratio
1.54×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $180K | $1.4M | $1.4M | $0 | $0 | $0 |
| R&D expense |
Balance sheet
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $72.4M | $37.3M | $15.3M | $2.9M | — | $7.8M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$43.7M | -$47.2M | -$27.5M | -$16.5M | -$16.4M | -$19.8M |
| Capital expenditures |
Get BYSI data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/BYSI/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/BYSI/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"